Chinese vaping brand Aspire Global sets terms for $120 million US IPO

Aspire Global, an e-cigarette and vaping brand, announced terms for its IPO on Friday.

The Shenzhen, China-based company plans to raise $120 million by offering 15 million shares at a price range of $7 to $9. At the midpoint of the proposed range, Aspire Global would command a market value of $1.3 billion.

Aspire is a vertically integrated provider of e-cigarette vaporizing technology. Its tobacco vaping products are sold through a distribution network of more than 150 distributors in 30 countries. In December 2020, the company also commenced the marketing of cannabis vaping technology products in the US.

Aspire Global was founded in 2010 and booked $82 million in sales for the 12 months ended December 31, 2020. It plans to list on the Nasdaq under the symbol ASPG. Tiger Brokers, EF Hutton, TF International, and China Merchants Securities are the joint bookrunners on the deal.

The article Chinese vaping brand Aspire Global sets terms for $120 million US IPO originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com.

Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital's Renaissance IPO ETF (symbol: IPO), Renaissance International ETF (symbol: IPOS), or separately managed institutional accounts may have investments in securities of companies mentioned.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story


Latest IPOs Videos

    Sono-Tek Corporation Rings the Nasdaq Stock Market Closing Bell in Celebration of its IPO

    Sono-Tek Corporation (Nasdaq: SOTK) visits the Nasdaq MarketSite in Times Square.

    In honor of the occasion, Christopher Coccio, CEO, rings the Closing Bell.

    Sep 6, 2021

    Renaissance Capital

    Renaissance Capital is the global leader in providing pre-IPO institutional research and management of IPO-focused investment products.

    Learn More